Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Avera McKennan Hospital & University Health Center
Cancer Research UK
Jonsson Comprehensive Cancer Center
Cancer Research UK
Cancer Research UK
Washington University School of Medicine
Dana-Farber Cancer Institute
Arbeitsgemeinschaft medikamentoese Tumortherapie
MacroGenics
Celgene
Novartis
CureOne
Novartis
Novartis